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Introduction
Microcin J25 (MccJ25) is a 21-residue ribosomally synthesized antimicrobial peptide that adopts a remarkable threaded-lasso structure. [1] [2] [3] MccJ25 displays bactericidal activity against a range of food-borne disease-causing Gram-negative pathogens including diarrheagenic E. coli strains. 4 The lasso-structure of the peptide consists of a lactam ring (known as lariat ring)
formed between the N-terminus Gly1 and the side chain of Glu8 ( Figure 1) . [5] [6] [7] The C-terminal tail (Tyr9-Gly21) passes through the ring forming a β-hairpin structure made of a type I β-turn (Val11-Gly14) and two short double stranded antiparallel β-sheets, residues 6-7/19-20 and 10-11/15-16.
The active mature MccJ25 is produced and exported by four plasmid-encoded genes mcjABCD. 8 McjA encodes a linear 58-residue precursor peptide which is converted into mature peptide by two enzymes, McjB and McjC. 9, 10 McjB, a putative peptidase, cleaves the 37-residue leader peptide from the precursor peptide, whereas, McjC is believed to catalyze the lactam bond formation. McjD helps in the transport of the active antibiotic peptide out of the producing cell.
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The lasso-structure confers several properties to MccJ25, such as, resistance to proteolytic degradation, 12, 13 stability towards chaotropes, organic solvents, and extreme temperatures. 14 Such properties make MccJ25 a potential candidate for a number of applications including food preservation and treatment of food-borne diseases.
Different variants of MccJ25, prepared by site directed mutagenesis, have been reported for studying structure activity relationship (SAR). 15 , 16 Pavlova et al. performed a complete mutational scanning analysis of MccJ25 by making more than 380 MccJ25 variants with a single amino acid substitution. 16 Each single amino acid variant was tested for production and export from E.coli. In addition, the variants that were produced were analyzed for the ability to inhibit RNA polymerase (RNAP) and bacterial growth. Several residues in the lactam ring and the tail region were found to be important for the production of MccJ25 and inhibition of bacterial growth. Another study reported MccJ25 variants containing two or three amino acid substitutions where the peptides retain the lasso structure and the antimicrobial function. 15 These studies demonstrate that peptide lasso scaffold of MccJ25 is quite tolerant to amino acid substitutions. Additional SAR studies of MccJ25 have suggested that the lactam ring region and the tail β-hairpin loop play distinct roles in the peptide's antimicrobial activity. 17, 18 In particular, using a thermolysin-digested MccJ25 cleaved between residues 10 and 11 it was demonstrated that the β-hairpin (residues 10-16) is crucial in the import of MccJ25 through FhuA, but not for RNAP and respiration inhibition. 18 The roles played by specific residues in the peptide have also been reported. 19, 20 The C-terminal glycine was found to be important for RNAP inhibition, 19 while site specific mutation of His-5 demonstrated that this residue was important for recognition by the inner membrane receptor SbmA. and propargyl glycine, respectively. 5, 6, 21 In the later variant (cMccJ25), the copper-catalyzed click reaction between the azide and the terminal alkyne permits cyclization of cMccJ25 without the influence of the maturation enzymes. 21 None of these synthetic peptides showed any antibacterial activity.
We hypothesized that peptides with antibacterial activity can be designed based on the shown in yellow for cysteine and red for others.
Results and Discussion
Six peptides were designed on the basis of the MccJ25 sequence following the strategy that intra-peptide interactions will lead to active peptide derivatives. Peptides were designed to form folded conformation by intra-peptide (i) disulfide and amide bond formation (analogues 1 and 2), (ii) disulfide and electrostatic interactions (3 and 4), or (iii) disulfide and hydrophobic interactions (5 and 6). In peptide 1, the lactam ring of MccJ25 between G1 and E8 was maintained, and a disulfide bond between C4 and C20 (C-terminal) was introduced to hold the C-terminal of the peptide in place. In all other peptides (2-6), the isopeptide bond between G1
and E8 was replaced with a disulfide bond. Peptide 2, an 18-residue peptide, utilized an amide bond to tie the N-terminal C1 with the C-terminal E18. Peptides 3 and 4 contain substitution of a ring residue and one residue from the tail region with positively and negatively charged amino acids, respectively, for electrostatic interactions (H5K, Y20E in 3 and G4K, Y20E in 4).
Similarly, peptides 5 and 6 contain substitution or insertion with hydrophobic amino acids, such as G4F in 5. Peptide 6 consists of a larger 9-residue N-terminal ring, as expansion of the ring was thought to facilitate the insertion of the C-terminal into the N-terminal lariat ring by interaction between F5 and F19 and/or Y20. An aromatic hydrophobic Phe (F) residue was inserted between G4 and H5 for enhanced van der Waals and stacking interactions with the Cterminal F19 and Y20. In addition, I13R and/or T15G substitutions (replacement of hydrophobic Ile with basic guanidine containing Arg and Thr with a methyl side chain with Gly with no side chain) were introduced in peptides 2, 5, and 6 to increase solubility. These mutations have been reported to yield higher inhibitory activity compared to the wild-type MccJ25.
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Peptides 1-6 were synthesized as linear peptides using Fmoc solid-phase peptide synthesis. For peptides 1 and 2, the lactam bond formation was achieved on the solid-phase, followed by cleavage from the resin. The second ring (disulfide bond) was then formed in solution. Peptides 3-6 were cleaved from the resin as linear peptides followed by oxidation to form disulfide bond. The electrostatic or hydrophobic interactions in the peptides were initiated when the peptides were cleaved from the solid phase and the side chain protections were removed. Native MccJ25 was expressed using pTUC202 plasmid in E. coli MC4100 in M9 minimal media. 12 Crude peptides were purified using semi-preparative reversed-phase HPLC prior to characterization by electrospray and/or MALDI-TOF mass spectrometry (Table S1, supplementary data). All peptides were purified up to >95% purity as shown by analytical RP-HPLC and mass spectrometry (Figures S1 and S2), and were obtained with an overall yield of 7-32%.
The antibacterial activity of MccJ25 and peptides 1-6 was evaluated against a number of Gram-negative pathogens. Twelve Salmonella strains and two E. coli strains were used to obtain the activity profile of the peptides using liquid growth inhibition assay (Table 1) . 22 newport have been reported previously. 3, 12, 23, 24 In this study, we found the MIC value of MccJ25 to be 0.5 M against a clinical isolate of S. newport. This variation in MIC values could be due to the difference in the experimental conditions used, such as spot-on-lawn assay, liquid growth assay, media with or without supplements, or the difference in the strains used. 
5.0 ± 2.0 --a Details for the bacterial strains are provided in Table S2 ( Circular dichroism (CD) spectroscopy was used to study the folding behavior of peptides 1 and 6 in solution. Methanol was used as a solvent for CD studies due to the limited solubility of the peptides in water. Moreover, methanol has been used previously to elucidate the solution structure (NMR structure) of MccJ25. 6 The CD spectra of peptides 1 and 6 in methanol were with the previously reported spectrum. 25 A negative peak at 200 nm is characteristic of unstructured peptides; however, this peak has also been attributed to small -sheets or β-turn secondary structures such as in β-defensins. 26 The positive band at ca. 225 and 210 nm have been attributed to the Phe La and Tyr La transitions. 27 CD of peptide 1 showed a broad minimum at 208 nm with low intensity (= -1.5 x 10 3 ), whereas, peptide 6 displayed a minimum at 210 nm (= -5.0 x 10 3 ) with a shoulder at 226 nm (= -1.8 x 10 3 ). Quantitative analysis of the secondary structure of peptide 6 with CDPro 28 suggested that there is little -sheet conformation (~ 15% residues form -sheet) compared to MccJ25 (39%). Peptide 6 showed the presence of increased helical folding. These results suggest that both the active peptides (1 and 6) may adopt a constrained and compact folded structure, however, do not adopt the true lasso structure as observed in MccJ25. Furthermore, the absence of lasso conformation in peptides 1 and 6 was confirmed by enzyme stability studies. MccJ25 is known to be highly stable to degradation in the presence of proteolytic enzymes, such as chymotrypsin, trypsin, carboxypeptidase and pepsin. 12 In contrast, both 1 and 6 were not stable in the presence of chymotrypsin and pepsin. During the antimicrobial assay, the circular growth inhibition zones of 1 and 6 were distorted to a crescent- and Glu8) allowing access to the C-terminal residues for cleavage by enzymes such as pepsin.
Peptide 6 also gave similar degradation products after incubation with pepsin. However, fragments from cleavage near Phe5 residue, which is present inside the N-terminal ring (between Cys1 and Cys9) of 6, were not detected. Interestingly, the evaluation of thermostability of 1 and 6 showed that only peptide 1 was active after incubation in boiling water for 3 hours. This may be due to its rigid bicyclic ring structure allowing high heat resistance similar to wild-type
MccJ25. The disulfide bond was found to be intact for peptide 1 after boiling treatment.
Peptides 1 and 6 with reduced cysteine residues (absence of disulfide bond) were found to display no antimicrobial activity. To assess the effect of peptides 1 and 6 on the inhibition of cell respiration, the oxygen consumption of Salmonella newport in the presence of MccJ25, 1 or 6 was assayed. Peptide 1 inhibited oxygen consumption, whereas, peptide 6 had no effect on oxygen consumption ( Figure   5 ). The findings from this experiment suggest that peptide 1 inhibits cell respiration in a manner analogous to MccJ25, and peptide 6 that did not inhibit cell respiration has an alternative mechanism of action. Peptide 1, which lacks the lasso structure, seems to act primarily by inhibition of cell respiration which may also account for its decreased antimicrobial activity compared to MccJ25. Peptides 3-4 with charged residues or involving electrostatic interactions displayed slightly higher cytotoxic effect (75% cell viability) compared to the other peptides (> 90% cell viability).
Fragment
In general, the toxicity values observed were not significant when compared to the known antitumor agents. In this context, it is of particular interest to note that Lopez et al. observed low hemolytic activity for MccJ25 against red blood cells. 24 Although MccJ25 displays antiapoptotic properties with isolated mitochondria, 31 the low cytotoxicity could be due to its inability to permeate human cells. 
Experimental Section

Reagents and Equipment
Wang resin (0.58 mmol/g), N-α-Fmoc-amino acids, benzotriazol-L-yl-oxy-tris- 
Peptide Synthesis and Purification
General procedure
Stepwise synthesis of peptides 1-6 was done manually on a 0.2-mmol scale of Wang resin (1.0% DVB cross-linked), following the standard Fmoc solid-phase peptide chemistry as described previously. 32 Attachment of the first amino acid (5 equivalent) was carried out using 2, 6 dichlorobenzoylchloride (DCB) in DMF/pyridine mixture. Successive couplings were performed by dissolving an excess (2 equiv) of Fmoc-protected amino acid and Castro reagent (BOP) in presence of (HOBt) to prevent racemization in DMF. Coupling efficiency was monitored using the ninhydrin (Kaiser) test. 33 The coupling step was repeated (double coupling)
if Kaiser test was found positive. In addition, a test cleavage was performed after each five residues were coupled, and the desired product was confirmed by MALDI-TOF mass spectrometry. Each peptide was cleaved from the resin using a mixture of 95% TFA, 5% triisopropylsilane, 5% water, for 120 minutes at room temperature with mechanical shaking. The filtrate from the cleavage reactions was collected, combined with TFA washes (3 x 2 min, 1 mL), and concentrated in vacuum. Cold diethyl ether (~ 15 mL) was added to precipitate the crude cleaved peptide. After triturating for 2 min, the peptide was collected upon centrifugation and decantation of the ether. The peptides were then purified using RP-HPLC.
On resin amide cyclization (Peptides 1 and 2)
For peptides 1 and 2, side chain of Glu was protected as allyl ester (OAll). After complete assembly of the protected peptide on the resin, the side chain protecting group (allyl) of Glu8 (peptide 1) or Glu18 (peptide 2) was first removed. Deprotection of the allyl from carboxyl group was carried out with Pd(PPh3)4 (0.08 equiv) and PhSiH3 (8 equiv) in DCM/DMF (45 mins x 3) under nitrogen. The N-terminus Fmoc group was removed using 20% piperidine/DMF. The desired lactam linkage was then formed using HATU/DIPEA (2 equivalent) as the activating agents for 3 hours in DMF, after which complete cyclization was achieved. It was confirmed using ninhydrin test and MALDI-TOF.
Oxidative folding and disulfide bond formation
The purified linear (analogues 3-6) or lactam cyclized peptides (1-2) were dissolved in 50 
Peptide purification
Purification of the peptides was done in two stages. First, the crude linear or lactam cyclized peptides were reconstituted in 30-50% aqueous acetonitrile and purified on a semipreparative Vydac C18 reversed-phase (RP) HPLC column (10 x 250 mm, 5 μm, flow rate = 2 mL/min, monitored at 220 nm) using different linear gradients of acetonitrile/water or isopropyl alcohol/water (0.05% TFA, v/v) mixtures. The peptides were oxidized to form the disulfide bond, and were subjected to another RP-HPLC purification using preparative C18 HPLC column (21.2 x 250 mm, 7 µm). This purification was essentially done to remove the salts from the reaction mixture. The collected fractions were evaporated on the rotary evaporator followed by lyophilization to obtain the pure peptide. The identity and purity of the peptides were assessed by analytical HPLC ( Figure S1 ) and MALDI-TOF mass spectrometry ( Figure S2 ). The details of the purification methods and the elution time of each peptide are listed in Table S1 . In general, pure peptides were obtained with an overall yield of 7-32% and purity greater than 95%.
Microcin J25 Expression and Purification
The expression and purification of native MccJ25 were performed as described previously with some modifications. 12 Briefly, the high copy number plasmid pTUC202 (a gift from Rutgers University, USA) which carries the MccJ25 biosynthetic gene cluster was M/L), 18 and the yield was 2 mg.
Antimicrobial Activity Assay
The minimum inhibitory concentrations (MICs) of peptides 1, 6 and MccJ25 were determined by liquid growth inhibition assays in sterile 96-well plate using LB as growth media. 22 Peptide stock solutions were prepared in 20% methanol/water (1 mM for MccJ55 and was read at 620 nm on a plate reader. MICs were defined from a growth curve as the lowest peptide concentrations that caused 100% growth inhibition (0.05 AU). Three representative growth curves of microcin J25, peptide 1, and peptide 6 obtained using broth assay against Salmonella newport are shown in Figure S4 . Standard deviations derived from MIC outcome of three graphs for three repeated experiments were calculated. Concentrations of peptides stocks solutions were determined by absorbance at 280 nm described previously. 35 The minimum bactericidal concentration (MBC) was determined from wells showing complete inhibition. An LB agar plate was seeded on the surface with 10 μL from each clear well and incubated (24 h, 37°C). The MBC was defined as the lowest concentration giving no growth on an LB plate afterwards.
Circular Dichroism (CD) Spectroscopy
The CD measurements for the peptides (MccJ25, 1 and 6) were made on an Olis CD spectrometer (Georgia, USA) at 25 C in a thermally controlled quartz cell over 190-260 nm.
All samples were dissolved in 100% methanol with a final concentration of 200 µM. The length of the cuvette was 0.02 cm and number of scans was set to 10. Smoothing and correction of the background spectra was performed afterwards. The CD data was normalized and expressed in terms of mean residue ellipticity (deg cm 2 dmol -1 ). CD spectra were analyzed using quantitative curve fitting using the CDPro software analysis program as described previously. 
Proteolytic Stability
The enzymatic stability of peptides 1 and 6 compared to native MccJ25 was evaluated against two digestive enzymes (pepsin and chymotrypsin). The susceptibility of 1 and 6 for chymotrypsin cleavage was assessed using spot on lawn method as reported previously. 13 Peptide analogues 1 and 6 (10 L of 200 M) were spotted onto LB plates and chymotrypsin solution (10 µL of 0.5 mg/mL) was placed 1 cm away from the peptide spots. After the drops had dried, the plates were overlaid with 4 mL of soft agar inoculated with 10 7 cells of a clinical isolate of Salmonella enterica serovar Newport. After overnight incubation at 37 °C, the growth inhibition zones around the drops were recorded. MccJ25 was used as control at 5 M concentration.
Pepsin was dissolved in 0.1 N HCl (4% w/w) and then peptide 1 or 6 was added (150 M). 37 The solution was incubated at 37 °C and the degradation was stopped at specific time points 0 min, 30 min, 1 hr, by taking 100 μL aliquots into 10 μL 0.1 N NaOH containing 70% methanol to precipitate the enzyme. Sample was centrifuged at 16000 g for 10 min, and the supernatant containing the cleavage mixture was injected in RP-HPLC. Fractions were collected for mass detection using MALDI-TOF to determine the labile sites. Also fragments were analyzed for antibacterial activity using spot on Lawn as described earlier. For sake of comparison the same experiment was repeated for native MccJ25.
Oxygen Consumption Determination
Oxygen consumption was determined as previously described. 38 Salmonella newport strain were grown to exponential phase (OD600 0.4-0.5) in LB media. Samples were diluted in LB media to an OD600 of 0.2. Cells were then incubated at 37 °C with either MccJ25 (0.25 μM), 1 (25 μM), or 6 (30 μM) for 35 min. Thereafter, the average rate of respiration for subsequent 5 min was polographically measured with a 2 mL Gilson Clarke electrode oxygraph at 37 °C. A control experiment in the absence of peptide was carried out similarly.
Cell Viability Assay
Cell lines
Tumor cell lines used in this study included MDA-MB-435 and MCF7 breast cancer cell lines. MDA-MB-435 cells were cultured in RPMI 1640 medium (Sigma) supplemented with FBS (10%), penicillin (50 µg/mL), and streptomycin (0.05 g/mL) in a humidified atmosphere (5% CO2) at 37 C. MCF7 cells were grown in DMEM media supplemented with same additives as stated above.
MTT cytotoxicity assay
The cellular toxicity of MccJ25 and the peptide derivatives was determined by measuring the cell growth inhibition using MTT assay. 39 Two cancer cell lines were used, MDA-MB-435
and MCF7 cells. Cells were seeded in 96 well plates (Corning Inc., MA, USA) at a concentration of 1 x 10 4 cells/well (100 µL) in complete media and were incubated at 37 C in 5% CO2 atmosphere. After 24 hours, the cells were treated with aseptic samples. Samples (1 mM, MccJ25 and peptides) were prepared in sterile 10% DMSO/water followed by filtration through 0.2 μM filter. The cell culture media were added to the 96 well plate (180 μL/well) followed by addition of peptide sample solution (20 μL/well), serially double diluted to give concentrations ranging from 0.3125 to 100 μM. Doxorubicin was used as a positive control and untreated cells were used as a negative control. The plates were incubated for another 24 hours following which the culture media was aspirated and replaced with 100 μL MTT solution (5 mg/mL in media). The cells were incubated for 3.5 hours to allow interaction with MTT solution. Following incubation, the media was removed by vacuum, and the purple formazan product precipitated in each well was solubilized in DMSO (100 μL), and the absorbance was measured at 570 nm using microtitre reader. The percentage cell viability was expressed as the absorbance ratio of cells treated with peptides to untreated cells dissolved in complete media.
All experiments were done in triplicate, and the data is presented in the form of mean.
